# Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome

> **NCT06285214** · PHASE1 · COMPLETED · sponsor: **Imbrium Therapeutics** · enrollment: 47 (actual)

## Conditions studied

- Interstitial Cystitis/Bladder Pain Syndrome

## Interventions

- **DRUG:** V117957
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06285214
- **Lead sponsor:** Imbrium Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-26
- **Primary completion:** 2025-01-28
- **Final completion:** 2025-01-28
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285214

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285214, "Study of V117957 in Interstitial Cystitis/Bladder Pain Syndrome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06285214. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*